Serially Deposited Biomolecules on Polypyrrole Electrodes

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current immunoassays using conjugated antibodies are fragile, expensive, and difficult to produce reliably, limiting their robustness and accessibility for biomedical and biotechnology applications.

Innovation Solution

A method for creating a multiplex microarray with serially deposited biomolecules, including antibodies and oligonucleotides, on a CMOS microarray using electropolymerized polypyrrole, which allows for the attachment of biomolecules without chemical functionalization, enabling robust and cost-effective immunoassays.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conjugated antibodies are used in immunoassays, then detection sensitivity can be achieved, but the antibodies become fragile, expensive, and difficult to produce reliably

Engineering Contradiction:
Improvedetection sensitivityVSAvoidrobustness of antibody conjugates
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent extracts the antibody conjugation step from the immunoassay process by using unconjugated antibodies that bind to the electrode surface through the polypyrrole layer. This separation allows the antibody to function without being chemically modified, eliminating the fragility and production difficulties associated with conjugated antibodies while maintaining detection sensitivity through the electrochemical signal from the electrode.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The polypyrrole layer serves as an intermediary between the electrode and the antibody. It provides a stable, biocompatible surface that enables antibody binding without requiring chemical conjugation. This intermediary layer transfers the electrochemical signal from the electrode to the bound antibody, allowing sensitive detection while maintaining antibody integrity and reliability.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If conjugated antibodies are used in immunoassays, then detection can be performed, but production costs increase and reliability decreases

Engineering Contradiction:
Improvedetection capabilityVSAvoidproduction cost and reliability
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent employs disposable, unconjugated antibodies that can be easily produced and stored without the complex conjugation processes required for conventional immunoassays. The electrodes with polypyrrole coatings serve as single-use platforms that eliminate the need for expensive, fragile conjugated antibodies, reducing production costs while maintaining detection capability through electrochemical signaling.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

By extracting the conjugation step from the assay design, the patent enables the use of simple, inexpensive unconjugated antibodies. The detection function is achieved through the electrode's electrochemical signal rather than through conjugated antibody structures, significantly reducing manufacturing complexity and cost while improving reliability.

Inventive Principle:
Principle #2Taking out (Extraction)

3Productivity

If conventional ELISA methods are used, then immunoassays can be performed, but detection limits are less sensitive compared to the microarray method

Engineering Contradiction:
Improvedetection limit sensitivityVSAvoiddetection limit
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent replaces the mechanical/optical detection systems of conventional ELISA with electrochemical detection using voltage-gated ion channels and electrochemical signals from the electrode. This substitution enables direct measurement of ion flux and electrochemical changes, providing superior sensitivity and lower detection limits compared to the indirect optical or colorimetric methods used in ELISA.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the detection parameter from optical or colorimetric signals (used in ELISA) to electrochemical signals (voltage, current, ion flux). This parameter change enables detection at lower concentrations by utilizing the high sensitivity of electrochemical measurements, achieving detection limits at least an order of magnitude better than conventional ELISA methods.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The approach results in highly sensitive and specific immunoassays with improved robustness and reduced production costs, achieving detection limits at least an order of magnitude better than conventional ELISA methods, with the ability to detect biomolecules at low picogram per milliliter concentrations.

Implementation Method 1

electropolymerizing monomer on one or more microelectrodes of the microarray to form a polymer coating on the one or more microelectrodes

Methodology Applied
Scientific EffectElectropolymerization: Electrochemiluminescence

Implementation Method 2

exposing the microarray to a biomolecular solution containing a biomolecule for attachment to the polymer coating on the one or more electrodes

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS12135323B1Serially deposited biomolecules
Publication Date: 2024.11.05 CUSTOMARRAY INC
  • US12135323B1 patent drawing
  • US12135323B1 patent drawing
  • US12135323B1 patent drawing

AI summary

Disclosed herein is a multiplex microarray having serially attached non-functionalized biomolecules attached to a polymer coating covering each electrode of an array of electrodes for assays and a method of making the multiplex microarray. The method comprises serially blocking the electrodes of the microarray with a blocking protein, electropolymerizing pyrrole or a functionalized pyrrole on the electrodes where the biomolecule is not present during polymerization, exposing the microarray to a biomolecular solution containing a non-functionalized biomolecule for attachment to the polymer coating, and then repeating the steps to form the multiplex microarray.